Life Sciences: Racing the compliance timer? DSAR compliance and DOJ bulk data obligations in pharma and life sciences

Pharmaceutical and life sciences companies face two converging challenges. First, Data Subject Access Requests (DSAR) are forcing companies to know exactly where sensitive data lives and prove it on demand. Second, the US Department of Justice's (DOJ) Data Security Program limits where that data can be transferred, with a 10-year audit and reporting requirement attached. Different regulations, same root cause: ungoverned, unmapped sensitive data. Collibra's automated discovery, lineage and fulfillment capabilities close that gap.